Literature DB >> 12816754

Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model.

Warren H Lee1, John S Gounarides, Eric S Roos, Michael S Wolin.   

Abstract

Ischemia-reperfusion generates peroxynitrite (ONOO-), which interacts with many of the systems altered by ischemia-reperfusion. This study examines the influence of endogenously produced ONOO- on cardiac metabolism and function. Nitro-L-arginine (an inhibitor of ONOO- biosynthesis) and urate (a scavenger of ONOO-) were utilized to investigate potential pathophysiological roles for ONOO- in a rat Langendorff heart model perfused with glucose-containing saline at constant pressure and exposed to 30 min of ischemia followed by 60 min of reperfusion. In this model, ischemia-reperfusion decreased contractile function (e.g., left ventricular developed pressure), cardiac work (rate-pressure product), efficiency of O2 utilization, membrane-bound creatine kinase activity, and NMR-detectable ATP and creatine phosphate without significantly altering the recovery of coronary flow, heart rate, lactate release, and muscle pH. Treatment with urate and nitro-L-arginine produced a substantial recovery of left ventricular developed pressure, rate-pressure product, efficiency of O2 utilization, creatine kinase activity, and NMR-detectable creatine phosphate and a partial recovery of ATP. The pattern of effects observed in this study and in previously published work with similar models suggests that ONOO- may alter key steps in the efficiency of mitochondrial high-energy phosphate generation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816754     DOI: 10.1152/ajpheart.00808.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo.

Authors:  Sandra Levrand; Christine Vannay-Bouchiche; Benoît Pesse; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Free Radic Biol Med       Date:  2006-06-07       Impact factor: 7.376

Review 2.  Nitrosative stress and pharmacological modulation of heart failure.

Authors:  Pal Pacher; Richard Schulz; Lucas Liaudet; Csaba Szabó
Journal:  Trends Pharmacol Sci       Date:  2005-06       Impact factor: 14.819

Review 3.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 4.  Pyruvate enhancement of cardiac performance: Cellular mechanisms and clinical application.

Authors:  Robert T Mallet; Albert H Olivencia-Yurvati; Rolf Bünger
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-20

5.  The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury.

Authors:  Guang-Qing Huang; Jia-Ning Wang; Jun-Ming Tang; Lei Zhang; Fei Zheng; Jian-Ye Yang; Ling-Yun Guo; Xia Kong; Yong-Zhang Huang; Yong Liu; Shi-You Chen
Journal:  J Transl Med       Date:  2011-05-21       Impact factor: 5.531

6.  Effect of β-anhydroicaritin on the expression levels of tumor necrosis factor-α and matrix metalloproteinase-3 in periodontal tissue of diabetic rats.

Authors:  Yingtao Wu; Wanchun Wang; Lian Liu
Journal:  Mol Med Rep       Date:  2015-04-02       Impact factor: 2.952

7.  Early Steroid-Induced Osteonecrosis of Rabbit Femoral Head and Panax notoginseng Saponins: Mechanism and Protective Effects.

Authors:  Hui Qiang; Huitong Liu; Ming Ling; Kunzheng Wang; Chen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-16       Impact factor: 2.629

Review 8.  Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.

Authors:  Sarah Thompson; Beatriz Martínez-Burgo; Krishna Mohan Sepuru; Krishna Rajarathnam; John A Kirby; Neil S Sheerin; Simi Ali
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.